Virus in pancreas linked to diabetes type 1

16 March 2009

A team of UK researchers has found that a common family of enteroviruses may play an important role in triggering the development of diabetes,  particularly in children. These viruses usually cause symptoms similar  to the common cold, or vomiting and diarrhea. However, the team has now  provided evidence that they are also found frequently in the pancreas of  people who develop the sugar storage disorder.

The research, which was published in the March 6 issue of Diabetologia,  involved the detailed study of a unique collection of pancreases from 72  young people who died less than a year after the diagnosis of type 1  diabetes.

A team of scientists led by Noel Morgan found that over 60% of the  organs contained evidence of enteroviral infection of the beta cells. By  contrast, infected beta cells were hardly ever seen in tissue samples  from 50 children without the condition.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight